HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trialsDaniel I. Swerdlow, Rudi G. J. Westendorp, Maarten Leusink et al.|The Lancet|2014Cited by 709
SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in EuropeLisa Pennells, Panagiotis Vardas, Stephen Kaptoge et al.|European Heart Journal|2023Cited by 299
Association of Smoking, Alcohol Consumption, Blood Pressure, Body Mass Index, and Glycemic Risk Factors With Age-Related Macular DegenerationValerie Kuan, Ian L. McAllister, Alasdair Warwick et al.|JAMA Ophthalmology|2021Cited by 93
Ethnic disparities in progression rates for sight-threatening diabetic retinopathy in diabetic eye screening: a population-based retrospective cohort studyAbraham Olvera‐Barrios, Alicja R. Rudnicka, Christopher G. Owen et al.|BMJ Open Diabetes Research & Care|2023Cited by 12
Two-year recall for people with no diabetic retinopathy: a multi-ethnic population-based retrospective cohort study using real-world data to quantify the effectAbraham Olvera‐Barrios, Christopher G. Owen, Alicja R. Rudnicka et al.|British Journal of Ophthalmology|2023Cited by 10